Medical Care
Diagnostic Biomarkers - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Sep 11, 24
- ID: 549912
- Pages: 108
- Figures: 175
- Views: 4
The global market for Diagnostic Biomarkers was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Diagnostic Biomarkers, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Diagnostic Biomarkers by region & country, by Type, and by Application.
The Diagnostic Biomarkers market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnostic Biomarkers.
Market Segmentation
By Company
Qiagen N.V.
Perkinelmer, Inc.
Merck Millipore
Bio-Rad Laboratories, Inc.
Enzo Biochem, Inc.
EKF Diagnostics Holdings, Inc.
Meso Scale Diagnostics, LLC.
Biosims Technologies Sas
Cisbio Bioassays
Signosis, Inc
Banyan Biomarkers, Inc
Biomedical Corp
Segment by Type:
Safety Biomarkers
Efficacy Biomarkers
Validation Biomarkers
Segment by Application
Hospitals
Cancer Research Institutes
Diagnostic Labs
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Diagnostic Biomarkers manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Diagnostic Biomarkers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Diagnostic Biomarkers in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Diagnostic Biomarkers, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Diagnostic Biomarkers by region & country, by Type, and by Application.
The Diagnostic Biomarkers market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnostic Biomarkers.
Market Segmentation
By Company
Qiagen N.V.
Perkinelmer, Inc.
Merck Millipore
Bio-Rad Laboratories, Inc.
Enzo Biochem, Inc.
EKF Diagnostics Holdings, Inc.
Meso Scale Diagnostics, LLC.
Biosims Technologies Sas
Cisbio Bioassays
Signosis, Inc
Banyan Biomarkers, Inc
Biomedical Corp
Segment by Type:
Safety Biomarkers
Efficacy Biomarkers
Validation Biomarkers
Segment by Application
Hospitals
Cancer Research Institutes
Diagnostic Labs
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Diagnostic Biomarkers manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Diagnostic Biomarkers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Diagnostic Biomarkers in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Diagnostic Biomarkers Product Introduction
1.2 Global Diagnostic Biomarkers Market Size Forecast
1.3 Diagnostic Biomarkers Market Trends & Drivers
1.3.1 Diagnostic Biomarkers Industry Trends
1.3.2 Diagnostic Biomarkers Market Drivers & Opportunity
1.3.3 Diagnostic Biomarkers Market Challenges
1.3.4 Diagnostic Biomarkers Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Diagnostic Biomarkers Players Revenue Ranking (2023)
2.2 Global Diagnostic Biomarkers Revenue by Company (2019-2024)
2.3 Key Companies Diagnostic Biomarkers Manufacturing Base Distribution and Headquarters
2.4 Key Companies Diagnostic Biomarkers Product Offered
2.5 Key Companies Time to Begin Mass Production of Diagnostic Biomarkers
2.6 Diagnostic Biomarkers Market Competitive Analysis
2.6.1 Diagnostic Biomarkers Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Diagnostic Biomarkers Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Biomarkers as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Safety Biomarkers
3.1.2 Efficacy Biomarkers
3.1.3 Validation Biomarkers
3.2 Global Diagnostic Biomarkers Sales Value by Type
3.2.1 Global Diagnostic Biomarkers Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Diagnostic Biomarkers Sales Value, by Type (2019-2030)
3.2.3 Global Diagnostic Biomarkers Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Cancer Research Institutes
4.1.3 Diagnostic Labs
4.2 Global Diagnostic Biomarkers Sales Value by Application
4.2.1 Global Diagnostic Biomarkers Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Diagnostic Biomarkers Sales Value, by Application (2019-2030)
4.2.3 Global Diagnostic Biomarkers Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Diagnostic Biomarkers Sales Value by Region
5.1.1 Global Diagnostic Biomarkers Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Diagnostic Biomarkers Sales Value by Region (2019-2024)
5.1.3 Global Diagnostic Biomarkers Sales Value by Region (2025-2030)
5.1.4 Global Diagnostic Biomarkers Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Diagnostic Biomarkers Sales Value, 2019-2030
5.2.2 North America Diagnostic Biomarkers Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Diagnostic Biomarkers Sales Value, 2019-2030
5.3.2 Europe Diagnostic Biomarkers Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Diagnostic Biomarkers Sales Value, 2019-2030
5.4.2 Asia Pacific Diagnostic Biomarkers Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Diagnostic Biomarkers Sales Value, 2019-2030
5.5.2 South America Diagnostic Biomarkers Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Diagnostic Biomarkers Sales Value, 2019-2030
5.6.2 Middle East & Africa Diagnostic Biomarkers Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Diagnostic Biomarkers Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Diagnostic Biomarkers Sales Value
6.3 United States
6.3.1 United States Diagnostic Biomarkers Sales Value, 2019-2030
6.3.2 United States Diagnostic Biomarkers Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Diagnostic Biomarkers Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Diagnostic Biomarkers Sales Value, 2019-2030
6.4.2 Europe Diagnostic Biomarkers Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Diagnostic Biomarkers Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Diagnostic Biomarkers Sales Value, 2019-2030
6.5.2 China Diagnostic Biomarkers Sales Value by Type (%), 2023 VS 2030
6.5.3 China Diagnostic Biomarkers Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Diagnostic Biomarkers Sales Value, 2019-2030
6.6.2 Japan Diagnostic Biomarkers Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Diagnostic Biomarkers Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Diagnostic Biomarkers Sales Value, 2019-2030
6.7.2 South Korea Diagnostic Biomarkers Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Diagnostic Biomarkers Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Diagnostic Biomarkers Sales Value, 2019-2030
6.8.2 Southeast Asia Diagnostic Biomarkers Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Diagnostic Biomarkers Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Diagnostic Biomarkers Sales Value, 2019-2030
6.9.2 India Diagnostic Biomarkers Sales Value by Type (%), 2023 VS 2030
6.9.3 India Diagnostic Biomarkers Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Qiagen N.V.
7.1.1 Qiagen N.V. Profile
7.1.2 Qiagen N.V. Main Business
7.1.3 Qiagen N.V. Diagnostic Biomarkers Products, Services and Solutions
7.1.4 Qiagen N.V. Diagnostic Biomarkers Revenue (US$ Million) & (2019-2024)
7.1.5 Qiagen N.V. Recent Developments
7.2 Perkinelmer, Inc.
7.2.1 Perkinelmer, Inc. Profile
7.2.2 Perkinelmer, Inc. Main Business
7.2.3 Perkinelmer, Inc. Diagnostic Biomarkers Products, Services and Solutions
7.2.4 Perkinelmer, Inc. Diagnostic Biomarkers Revenue (US$ Million) & (2019-2024)
7.2.5 Perkinelmer, Inc. Recent Developments
7.3 Merck Millipore
7.3.1 Merck Millipore Profile
7.3.2 Merck Millipore Main Business
7.3.3 Merck Millipore Diagnostic Biomarkers Products, Services and Solutions
7.3.4 Merck Millipore Diagnostic Biomarkers Revenue (US$ Million) & (2019-2024)
7.3.5 Bio-Rad Laboratories, Inc. Recent Developments
7.4 Bio-Rad Laboratories, Inc.
7.4.1 Bio-Rad Laboratories, Inc. Profile
7.4.2 Bio-Rad Laboratories, Inc. Main Business
7.4.3 Bio-Rad Laboratories, Inc. Diagnostic Biomarkers Products, Services and Solutions
7.4.4 Bio-Rad Laboratories, Inc. Diagnostic Biomarkers Revenue (US$ Million) & (2019-2024)
7.4.5 Bio-Rad Laboratories, Inc. Recent Developments
7.5 Enzo Biochem, Inc.
7.5.1 Enzo Biochem, Inc. Profile
7.5.2 Enzo Biochem, Inc. Main Business
7.5.3 Enzo Biochem, Inc. Diagnostic Biomarkers Products, Services and Solutions
7.5.4 Enzo Biochem, Inc. Diagnostic Biomarkers Revenue (US$ Million) & (2019-2024)
7.5.5 Enzo Biochem, Inc. Recent Developments
7.6 EKF Diagnostics Holdings, Inc.
7.6.1 EKF Diagnostics Holdings, Inc. Profile
7.6.2 EKF Diagnostics Holdings, Inc. Main Business
7.6.3 EKF Diagnostics Holdings, Inc. Diagnostic Biomarkers Products, Services and Solutions
7.6.4 EKF Diagnostics Holdings, Inc. Diagnostic Biomarkers Revenue (US$ Million) & (2019-2024)
7.6.5 EKF Diagnostics Holdings, Inc. Recent Developments
7.7 Meso Scale Diagnostics, LLC.
7.7.1 Meso Scale Diagnostics, LLC. Profile
7.7.2 Meso Scale Diagnostics, LLC. Main Business
7.7.3 Meso Scale Diagnostics, LLC. Diagnostic Biomarkers Products, Services and Solutions
7.7.4 Meso Scale Diagnostics, LLC. Diagnostic Biomarkers Revenue (US$ Million) & (2019-2024)
7.7.5 Meso Scale Diagnostics, LLC. Recent Developments
7.8 Biosims Technologies Sas
7.8.1 Biosims Technologies Sas Profile
7.8.2 Biosims Technologies Sas Main Business
7.8.3 Biosims Technologies Sas Diagnostic Biomarkers Products, Services and Solutions
7.8.4 Biosims Technologies Sas Diagnostic Biomarkers Revenue (US$ Million) & (2019-2024)
7.8.5 Biosims Technologies Sas Recent Developments
7.9 Cisbio Bioassays
7.9.1 Cisbio Bioassays Profile
7.9.2 Cisbio Bioassays Main Business
7.9.3 Cisbio Bioassays Diagnostic Biomarkers Products, Services and Solutions
7.9.4 Cisbio Bioassays Diagnostic Biomarkers Revenue (US$ Million) & (2019-2024)
7.9.5 Cisbio Bioassays Recent Developments
7.10 Signosis, Inc
7.10.1 Signosis, Inc Profile
7.10.2 Signosis, Inc Main Business
7.10.3 Signosis, Inc Diagnostic Biomarkers Products, Services and Solutions
7.10.4 Signosis, Inc Diagnostic Biomarkers Revenue (US$ Million) & (2019-2024)
7.10.5 Signosis, Inc Recent Developments
7.11 Banyan Biomarkers, Inc
7.11.1 Banyan Biomarkers, Inc Profile
7.11.2 Banyan Biomarkers, Inc Main Business
7.11.3 Banyan Biomarkers, Inc Diagnostic Biomarkers Products, Services and Solutions
7.11.4 Banyan Biomarkers, Inc Diagnostic Biomarkers Revenue (US$ Million) & (2019-2024)
7.11.5 Banyan Biomarkers, Inc Recent Developments
7.12 Biomedical Corp
7.12.1 Biomedical Corp Profile
7.12.2 Biomedical Corp Main Business
7.12.3 Biomedical Corp Diagnostic Biomarkers Products, Services and Solutions
7.12.4 Biomedical Corp Diagnostic Biomarkers Revenue (US$ Million) & (2019-2024)
7.12.5 Biomedical Corp Recent Developments
8 Industry Chain Analysis
8.1 Diagnostic Biomarkers Industrial Chain
8.2 Diagnostic Biomarkers Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Diagnostic Biomarkers Sales Model
8.5.2 Sales Channel
8.5.3 Diagnostic Biomarkers Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Diagnostic Biomarkers Product Introduction
1.2 Global Diagnostic Biomarkers Market Size Forecast
1.3 Diagnostic Biomarkers Market Trends & Drivers
1.3.1 Diagnostic Biomarkers Industry Trends
1.3.2 Diagnostic Biomarkers Market Drivers & Opportunity
1.3.3 Diagnostic Biomarkers Market Challenges
1.3.4 Diagnostic Biomarkers Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Diagnostic Biomarkers Players Revenue Ranking (2023)
2.2 Global Diagnostic Biomarkers Revenue by Company (2019-2024)
2.3 Key Companies Diagnostic Biomarkers Manufacturing Base Distribution and Headquarters
2.4 Key Companies Diagnostic Biomarkers Product Offered
2.5 Key Companies Time to Begin Mass Production of Diagnostic Biomarkers
2.6 Diagnostic Biomarkers Market Competitive Analysis
2.6.1 Diagnostic Biomarkers Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Diagnostic Biomarkers Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Biomarkers as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Safety Biomarkers
3.1.2 Efficacy Biomarkers
3.1.3 Validation Biomarkers
3.2 Global Diagnostic Biomarkers Sales Value by Type
3.2.1 Global Diagnostic Biomarkers Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Diagnostic Biomarkers Sales Value, by Type (2019-2030)
3.2.3 Global Diagnostic Biomarkers Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Cancer Research Institutes
4.1.3 Diagnostic Labs
4.2 Global Diagnostic Biomarkers Sales Value by Application
4.2.1 Global Diagnostic Biomarkers Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Diagnostic Biomarkers Sales Value, by Application (2019-2030)
4.2.3 Global Diagnostic Biomarkers Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Diagnostic Biomarkers Sales Value by Region
5.1.1 Global Diagnostic Biomarkers Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Diagnostic Biomarkers Sales Value by Region (2019-2024)
5.1.3 Global Diagnostic Biomarkers Sales Value by Region (2025-2030)
5.1.4 Global Diagnostic Biomarkers Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Diagnostic Biomarkers Sales Value, 2019-2030
5.2.2 North America Diagnostic Biomarkers Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Diagnostic Biomarkers Sales Value, 2019-2030
5.3.2 Europe Diagnostic Biomarkers Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Diagnostic Biomarkers Sales Value, 2019-2030
5.4.2 Asia Pacific Diagnostic Biomarkers Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Diagnostic Biomarkers Sales Value, 2019-2030
5.5.2 South America Diagnostic Biomarkers Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Diagnostic Biomarkers Sales Value, 2019-2030
5.6.2 Middle East & Africa Diagnostic Biomarkers Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Diagnostic Biomarkers Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Diagnostic Biomarkers Sales Value
6.3 United States
6.3.1 United States Diagnostic Biomarkers Sales Value, 2019-2030
6.3.2 United States Diagnostic Biomarkers Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Diagnostic Biomarkers Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Diagnostic Biomarkers Sales Value, 2019-2030
6.4.2 Europe Diagnostic Biomarkers Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Diagnostic Biomarkers Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Diagnostic Biomarkers Sales Value, 2019-2030
6.5.2 China Diagnostic Biomarkers Sales Value by Type (%), 2023 VS 2030
6.5.3 China Diagnostic Biomarkers Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Diagnostic Biomarkers Sales Value, 2019-2030
6.6.2 Japan Diagnostic Biomarkers Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Diagnostic Biomarkers Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Diagnostic Biomarkers Sales Value, 2019-2030
6.7.2 South Korea Diagnostic Biomarkers Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Diagnostic Biomarkers Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Diagnostic Biomarkers Sales Value, 2019-2030
6.8.2 Southeast Asia Diagnostic Biomarkers Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Diagnostic Biomarkers Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Diagnostic Biomarkers Sales Value, 2019-2030
6.9.2 India Diagnostic Biomarkers Sales Value by Type (%), 2023 VS 2030
6.9.3 India Diagnostic Biomarkers Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Qiagen N.V.
7.1.1 Qiagen N.V. Profile
7.1.2 Qiagen N.V. Main Business
7.1.3 Qiagen N.V. Diagnostic Biomarkers Products, Services and Solutions
7.1.4 Qiagen N.V. Diagnostic Biomarkers Revenue (US$ Million) & (2019-2024)
7.1.5 Qiagen N.V. Recent Developments
7.2 Perkinelmer, Inc.
7.2.1 Perkinelmer, Inc. Profile
7.2.2 Perkinelmer, Inc. Main Business
7.2.3 Perkinelmer, Inc. Diagnostic Biomarkers Products, Services and Solutions
7.2.4 Perkinelmer, Inc. Diagnostic Biomarkers Revenue (US$ Million) & (2019-2024)
7.2.5 Perkinelmer, Inc. Recent Developments
7.3 Merck Millipore
7.3.1 Merck Millipore Profile
7.3.2 Merck Millipore Main Business
7.3.3 Merck Millipore Diagnostic Biomarkers Products, Services and Solutions
7.3.4 Merck Millipore Diagnostic Biomarkers Revenue (US$ Million) & (2019-2024)
7.3.5 Bio-Rad Laboratories, Inc. Recent Developments
7.4 Bio-Rad Laboratories, Inc.
7.4.1 Bio-Rad Laboratories, Inc. Profile
7.4.2 Bio-Rad Laboratories, Inc. Main Business
7.4.3 Bio-Rad Laboratories, Inc. Diagnostic Biomarkers Products, Services and Solutions
7.4.4 Bio-Rad Laboratories, Inc. Diagnostic Biomarkers Revenue (US$ Million) & (2019-2024)
7.4.5 Bio-Rad Laboratories, Inc. Recent Developments
7.5 Enzo Biochem, Inc.
7.5.1 Enzo Biochem, Inc. Profile
7.5.2 Enzo Biochem, Inc. Main Business
7.5.3 Enzo Biochem, Inc. Diagnostic Biomarkers Products, Services and Solutions
7.5.4 Enzo Biochem, Inc. Diagnostic Biomarkers Revenue (US$ Million) & (2019-2024)
7.5.5 Enzo Biochem, Inc. Recent Developments
7.6 EKF Diagnostics Holdings, Inc.
7.6.1 EKF Diagnostics Holdings, Inc. Profile
7.6.2 EKF Diagnostics Holdings, Inc. Main Business
7.6.3 EKF Diagnostics Holdings, Inc. Diagnostic Biomarkers Products, Services and Solutions
7.6.4 EKF Diagnostics Holdings, Inc. Diagnostic Biomarkers Revenue (US$ Million) & (2019-2024)
7.6.5 EKF Diagnostics Holdings, Inc. Recent Developments
7.7 Meso Scale Diagnostics, LLC.
7.7.1 Meso Scale Diagnostics, LLC. Profile
7.7.2 Meso Scale Diagnostics, LLC. Main Business
7.7.3 Meso Scale Diagnostics, LLC. Diagnostic Biomarkers Products, Services and Solutions
7.7.4 Meso Scale Diagnostics, LLC. Diagnostic Biomarkers Revenue (US$ Million) & (2019-2024)
7.7.5 Meso Scale Diagnostics, LLC. Recent Developments
7.8 Biosims Technologies Sas
7.8.1 Biosims Technologies Sas Profile
7.8.2 Biosims Technologies Sas Main Business
7.8.3 Biosims Technologies Sas Diagnostic Biomarkers Products, Services and Solutions
7.8.4 Biosims Technologies Sas Diagnostic Biomarkers Revenue (US$ Million) & (2019-2024)
7.8.5 Biosims Technologies Sas Recent Developments
7.9 Cisbio Bioassays
7.9.1 Cisbio Bioassays Profile
7.9.2 Cisbio Bioassays Main Business
7.9.3 Cisbio Bioassays Diagnostic Biomarkers Products, Services and Solutions
7.9.4 Cisbio Bioassays Diagnostic Biomarkers Revenue (US$ Million) & (2019-2024)
7.9.5 Cisbio Bioassays Recent Developments
7.10 Signosis, Inc
7.10.1 Signosis, Inc Profile
7.10.2 Signosis, Inc Main Business
7.10.3 Signosis, Inc Diagnostic Biomarkers Products, Services and Solutions
7.10.4 Signosis, Inc Diagnostic Biomarkers Revenue (US$ Million) & (2019-2024)
7.10.5 Signosis, Inc Recent Developments
7.11 Banyan Biomarkers, Inc
7.11.1 Banyan Biomarkers, Inc Profile
7.11.2 Banyan Biomarkers, Inc Main Business
7.11.3 Banyan Biomarkers, Inc Diagnostic Biomarkers Products, Services and Solutions
7.11.4 Banyan Biomarkers, Inc Diagnostic Biomarkers Revenue (US$ Million) & (2019-2024)
7.11.5 Banyan Biomarkers, Inc Recent Developments
7.12 Biomedical Corp
7.12.1 Biomedical Corp Profile
7.12.2 Biomedical Corp Main Business
7.12.3 Biomedical Corp Diagnostic Biomarkers Products, Services and Solutions
7.12.4 Biomedical Corp Diagnostic Biomarkers Revenue (US$ Million) & (2019-2024)
7.12.5 Biomedical Corp Recent Developments
8 Industry Chain Analysis
8.1 Diagnostic Biomarkers Industrial Chain
8.2 Diagnostic Biomarkers Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Diagnostic Biomarkers Sales Model
8.5.2 Sales Channel
8.5.3 Diagnostic Biomarkers Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Diagnostic Biomarkers Market Trends
Table 2. Diagnostic Biomarkers Market Drivers & Opportunity
Table 3. Diagnostic Biomarkers Market Challenges
Table 4. Diagnostic Biomarkers Market Restraints
Table 5. Global Diagnostic Biomarkers Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Diagnostic Biomarkers Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Diagnostic Biomarkers Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Diagnostic Biomarkers Product Type
Table 9. Key Companies Time to Begin Mass Production of Diagnostic Biomarkers
Table 10. Global Diagnostic Biomarkers Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Biomarkers as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Diagnostic Biomarkers Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Diagnostic Biomarkers Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Diagnostic Biomarkers Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Diagnostic Biomarkers Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Diagnostic Biomarkers Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Diagnostic Biomarkers Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Diagnostic Biomarkers Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Diagnostic Biomarkers Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Diagnostic Biomarkers Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Diagnostic Biomarkers Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Diagnostic Biomarkers Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Diagnostic Biomarkers Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Diagnostic Biomarkers Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Diagnostic Biomarkers Sales Value by Region (2019-2024) & (%)
Table 27. Global Diagnostic Biomarkers Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Diagnostic Biomarkers Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Diagnostic Biomarkers Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Diagnostic Biomarkers Sales Value, (2025-2030) & (US$ Million)
Table 31. Qiagen N.V. Basic Information List
Table 32. Qiagen N.V. Description and Business Overview
Table 33. Qiagen N.V. Diagnostic Biomarkers Products, Services and Solutions
Table 34. Revenue (US$ Million) in Diagnostic Biomarkers Business of Qiagen N.V. (2019-2024)
Table 35. Qiagen N.V. Recent Developments
Table 36. Perkinelmer, Inc. Basic Information List
Table 37. Perkinelmer, Inc. Description and Business Overview
Table 38. Perkinelmer, Inc. Diagnostic Biomarkers Products, Services and Solutions
Table 39. Revenue (US$ Million) in Diagnostic Biomarkers Business of Perkinelmer, Inc. (2019-2024)
Table 40. Perkinelmer, Inc. Recent Developments
Table 41. Merck Millipore Basic Information List
Table 42. Merck Millipore Description and Business Overview
Table 43. Merck Millipore Diagnostic Biomarkers Products, Services and Solutions
Table 44. Revenue (US$ Million) in Diagnostic Biomarkers Business of Merck Millipore (2019-2024)
Table 45. Merck Millipore Recent Developments
Table 46. Bio-Rad Laboratories, Inc. Basic Information List
Table 47. Bio-Rad Laboratories, Inc. Description and Business Overview
Table 48. Bio-Rad Laboratories, Inc. Diagnostic Biomarkers Products, Services and Solutions
Table 49. Revenue (US$ Million) in Diagnostic Biomarkers Business of Bio-Rad Laboratories, Inc. (2019-2024)
Table 50. Bio-Rad Laboratories, Inc. Recent Developments
Table 51. Enzo Biochem, Inc. Basic Information List
Table 52. Enzo Biochem, Inc. Description and Business Overview
Table 53. Enzo Biochem, Inc. Diagnostic Biomarkers Products, Services and Solutions
Table 54. Revenue (US$ Million) in Diagnostic Biomarkers Business of Enzo Biochem, Inc. (2019-2024)
Table 55. Enzo Biochem, Inc. Recent Developments
Table 56. EKF Diagnostics Holdings, Inc. Basic Information List
Table 57. EKF Diagnostics Holdings, Inc. Description and Business Overview
Table 58. EKF Diagnostics Holdings, Inc. Diagnostic Biomarkers Products, Services and Solutions
Table 59. Revenue (US$ Million) in Diagnostic Biomarkers Business of EKF Diagnostics Holdings, Inc. (2019-2024)
Table 60. EKF Diagnostics Holdings, Inc. Recent Developments
Table 61. Meso Scale Diagnostics, LLC. Basic Information List
Table 62. Meso Scale Diagnostics, LLC. Description and Business Overview
Table 63. Meso Scale Diagnostics, LLC. Diagnostic Biomarkers Products, Services and Solutions
Table 64. Revenue (US$ Million) in Diagnostic Biomarkers Business of Meso Scale Diagnostics, LLC. (2019-2024)
Table 65. Meso Scale Diagnostics, LLC. Recent Developments
Table 66. Biosims Technologies Sas Basic Information List
Table 67. Biosims Technologies Sas Description and Business Overview
Table 68. Biosims Technologies Sas Diagnostic Biomarkers Products, Services and Solutions
Table 69. Revenue (US$ Million) in Diagnostic Biomarkers Business of Biosims Technologies Sas (2019-2024)
Table 70. Biosims Technologies Sas Recent Developments
Table 71. Cisbio Bioassays Basic Information List
Table 72. Cisbio Bioassays Description and Business Overview
Table 73. Cisbio Bioassays Diagnostic Biomarkers Products, Services and Solutions
Table 74. Revenue (US$ Million) in Diagnostic Biomarkers Business of Cisbio Bioassays (2019-2024)
Table 75. Cisbio Bioassays Recent Developments
Table 76. Signosis, Inc Basic Information List
Table 77. Signosis, Inc Description and Business Overview
Table 78. Signosis, Inc Diagnostic Biomarkers Products, Services and Solutions
Table 79. Revenue (US$ Million) in Diagnostic Biomarkers Business of Signosis, Inc (2019-2024)
Table 80. Signosis, Inc Recent Developments
Table 81. Banyan Biomarkers, Inc Basic Information List
Table 82. Banyan Biomarkers, Inc Description and Business Overview
Table 83. Banyan Biomarkers, Inc Diagnostic Biomarkers Products, Services and Solutions
Table 84. Revenue (US$ Million) in Diagnostic Biomarkers Business of Banyan Biomarkers, Inc (2019-2024)
Table 85. Banyan Biomarkers, Inc Recent Developments
Table 86. Biomedical Corp Basic Information List
Table 87. Biomedical Corp Description and Business Overview
Table 88. Biomedical Corp Diagnostic Biomarkers Products, Services and Solutions
Table 89. Revenue (US$ Million) in Diagnostic Biomarkers Business of Biomedical Corp (2019-2024)
Table 90. Biomedical Corp Recent Developments
Table 91. Key Raw Materials Lists
Table 92. Raw Materials Key Suppliers Lists
Table 93. Diagnostic Biomarkers Downstream Customers
Table 94. Diagnostic Biomarkers Distributors List
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
Table 98. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Diagnostic Biomarkers Product Picture
Figure 2. Global Diagnostic Biomarkers Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Diagnostic Biomarkers Sales Value (2019-2030) & (US$ Million)
Figure 4. Diagnostic Biomarkers Report Years Considered
Figure 5. Global Diagnostic Biomarkers Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Diagnostic Biomarkers Revenue in 2023
Figure 7. Diagnostic Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Safety Biomarkers Picture
Figure 9. Efficacy Biomarkers Picture
Figure 10. Validation Biomarkers Picture
Figure 11. Global Diagnostic Biomarkers Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Diagnostic Biomarkers Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Hospitals
Figure 14. Product Picture of Cancer Research Institutes
Figure 15. Product Picture of Diagnostic Labs
Figure 16. Global Diagnostic Biomarkers Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Diagnostic Biomarkers Sales Value Market Share by Application, 2023 & 2030
Figure 18. North America Diagnostic Biomarkers Sales Value (2019-2030) & (US$ Million)
Figure 19. North America Diagnostic Biomarkers Sales Value by Country (%), 2023 VS 2030
Figure 20. Europe Diagnostic Biomarkers Sales Value (2019-2030) & (US$ Million)
Figure 21. Europe Diagnostic Biomarkers Sales Value by Country (%), 2023 VS 2030
Figure 22. Asia Pacific Diagnostic Biomarkers Sales Value (2019-2030) & (US$ Million)
Figure 23. Asia Pacific Diagnostic Biomarkers Sales Value by Country (%), 2023 VS 2030
Figure 24. South America Diagnostic Biomarkers Sales Value (2019-2030) & (US$ Million)
Figure 25. South America Diagnostic Biomarkers Sales Value by Country (%), 2023 VS 2030
Figure 26. Middle East & Africa Diagnostic Biomarkers Sales Value (2019-2030) & (US$ Million)
Figure 27. Middle East & Africa Diagnostic Biomarkers Sales Value by Country (%), 2023 VS 2030
Figure 28. Key Countries/Regions Diagnostic Biomarkers Sales Value (%), (2019-2030)
Figure 29. United States Diagnostic Biomarkers Sales Value, (2019-2030) & (US$ Million)
Figure 30. United States Diagnostic Biomarkers Sales Value by Type (%), 2023 VS 2030
Figure 31. United States Diagnostic Biomarkers Sales Value by Application (%), 2023 VS 2030
Figure 32. Europe Diagnostic Biomarkers Sales Value, (2019-2030) & (US$ Million)
Figure 33. Europe Diagnostic Biomarkers Sales Value by Type (%), 2023 VS 2030
Figure 34. Europe Diagnostic Biomarkers Sales Value by Application (%), 2023 VS 2030
Figure 35. China Diagnostic Biomarkers Sales Value, (2019-2030) & (US$ Million)
Figure 36. China Diagnostic Biomarkers Sales Value by Type (%), 2023 VS 2030
Figure 37. China Diagnostic Biomarkers Sales Value by Application (%), 2023 VS 2030
Figure 38. Japan Diagnostic Biomarkers Sales Value, (2019-2030) & (US$ Million)
Figure 39. Japan Diagnostic Biomarkers Sales Value by Type (%), 2023 VS 2030
Figure 40. Japan Diagnostic Biomarkers Sales Value by Application (%), 2023 VS 2030
Figure 41. South Korea Diagnostic Biomarkers Sales Value, (2019-2030) & (US$ Million)
Figure 42. South Korea Diagnostic Biomarkers Sales Value by Type (%), 2023 VS 2030
Figure 43. South Korea Diagnostic Biomarkers Sales Value by Application (%), 2023 VS 2030
Figure 44. Southeast Asia Diagnostic Biomarkers Sales Value, (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Diagnostic Biomarkers Sales Value by Type (%), 2023 VS 2030
Figure 46. Southeast Asia Diagnostic Biomarkers Sales Value by Application (%), 2023 VS 2030
Figure 47. India Diagnostic Biomarkers Sales Value, (2019-2030) & (US$ Million)
Figure 48. India Diagnostic Biomarkers Sales Value by Type (%), 2023 VS 2030
Figure 49. India Diagnostic Biomarkers Sales Value by Application (%), 2023 VS 2030
Figure 50. Diagnostic Biomarkers Industrial Chain
Figure 51. Diagnostic Biomarkers Manufacturing Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Table 1. Diagnostic Biomarkers Market Trends
Table 2. Diagnostic Biomarkers Market Drivers & Opportunity
Table 3. Diagnostic Biomarkers Market Challenges
Table 4. Diagnostic Biomarkers Market Restraints
Table 5. Global Diagnostic Biomarkers Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Diagnostic Biomarkers Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Diagnostic Biomarkers Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Diagnostic Biomarkers Product Type
Table 9. Key Companies Time to Begin Mass Production of Diagnostic Biomarkers
Table 10. Global Diagnostic Biomarkers Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Biomarkers as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Diagnostic Biomarkers Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Diagnostic Biomarkers Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Diagnostic Biomarkers Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Diagnostic Biomarkers Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Diagnostic Biomarkers Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Diagnostic Biomarkers Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Diagnostic Biomarkers Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Diagnostic Biomarkers Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Diagnostic Biomarkers Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Diagnostic Biomarkers Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Diagnostic Biomarkers Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Diagnostic Biomarkers Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Diagnostic Biomarkers Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Diagnostic Biomarkers Sales Value by Region (2019-2024) & (%)
Table 27. Global Diagnostic Biomarkers Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Diagnostic Biomarkers Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Diagnostic Biomarkers Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Diagnostic Biomarkers Sales Value, (2025-2030) & (US$ Million)
Table 31. Qiagen N.V. Basic Information List
Table 32. Qiagen N.V. Description and Business Overview
Table 33. Qiagen N.V. Diagnostic Biomarkers Products, Services and Solutions
Table 34. Revenue (US$ Million) in Diagnostic Biomarkers Business of Qiagen N.V. (2019-2024)
Table 35. Qiagen N.V. Recent Developments
Table 36. Perkinelmer, Inc. Basic Information List
Table 37. Perkinelmer, Inc. Description and Business Overview
Table 38. Perkinelmer, Inc. Diagnostic Biomarkers Products, Services and Solutions
Table 39. Revenue (US$ Million) in Diagnostic Biomarkers Business of Perkinelmer, Inc. (2019-2024)
Table 40. Perkinelmer, Inc. Recent Developments
Table 41. Merck Millipore Basic Information List
Table 42. Merck Millipore Description and Business Overview
Table 43. Merck Millipore Diagnostic Biomarkers Products, Services and Solutions
Table 44. Revenue (US$ Million) in Diagnostic Biomarkers Business of Merck Millipore (2019-2024)
Table 45. Merck Millipore Recent Developments
Table 46. Bio-Rad Laboratories, Inc. Basic Information List
Table 47. Bio-Rad Laboratories, Inc. Description and Business Overview
Table 48. Bio-Rad Laboratories, Inc. Diagnostic Biomarkers Products, Services and Solutions
Table 49. Revenue (US$ Million) in Diagnostic Biomarkers Business of Bio-Rad Laboratories, Inc. (2019-2024)
Table 50. Bio-Rad Laboratories, Inc. Recent Developments
Table 51. Enzo Biochem, Inc. Basic Information List
Table 52. Enzo Biochem, Inc. Description and Business Overview
Table 53. Enzo Biochem, Inc. Diagnostic Biomarkers Products, Services and Solutions
Table 54. Revenue (US$ Million) in Diagnostic Biomarkers Business of Enzo Biochem, Inc. (2019-2024)
Table 55. Enzo Biochem, Inc. Recent Developments
Table 56. EKF Diagnostics Holdings, Inc. Basic Information List
Table 57. EKF Diagnostics Holdings, Inc. Description and Business Overview
Table 58. EKF Diagnostics Holdings, Inc. Diagnostic Biomarkers Products, Services and Solutions
Table 59. Revenue (US$ Million) in Diagnostic Biomarkers Business of EKF Diagnostics Holdings, Inc. (2019-2024)
Table 60. EKF Diagnostics Holdings, Inc. Recent Developments
Table 61. Meso Scale Diagnostics, LLC. Basic Information List
Table 62. Meso Scale Diagnostics, LLC. Description and Business Overview
Table 63. Meso Scale Diagnostics, LLC. Diagnostic Biomarkers Products, Services and Solutions
Table 64. Revenue (US$ Million) in Diagnostic Biomarkers Business of Meso Scale Diagnostics, LLC. (2019-2024)
Table 65. Meso Scale Diagnostics, LLC. Recent Developments
Table 66. Biosims Technologies Sas Basic Information List
Table 67. Biosims Technologies Sas Description and Business Overview
Table 68. Biosims Technologies Sas Diagnostic Biomarkers Products, Services and Solutions
Table 69. Revenue (US$ Million) in Diagnostic Biomarkers Business of Biosims Technologies Sas (2019-2024)
Table 70. Biosims Technologies Sas Recent Developments
Table 71. Cisbio Bioassays Basic Information List
Table 72. Cisbio Bioassays Description and Business Overview
Table 73. Cisbio Bioassays Diagnostic Biomarkers Products, Services and Solutions
Table 74. Revenue (US$ Million) in Diagnostic Biomarkers Business of Cisbio Bioassays (2019-2024)
Table 75. Cisbio Bioassays Recent Developments
Table 76. Signosis, Inc Basic Information List
Table 77. Signosis, Inc Description and Business Overview
Table 78. Signosis, Inc Diagnostic Biomarkers Products, Services and Solutions
Table 79. Revenue (US$ Million) in Diagnostic Biomarkers Business of Signosis, Inc (2019-2024)
Table 80. Signosis, Inc Recent Developments
Table 81. Banyan Biomarkers, Inc Basic Information List
Table 82. Banyan Biomarkers, Inc Description and Business Overview
Table 83. Banyan Biomarkers, Inc Diagnostic Biomarkers Products, Services and Solutions
Table 84. Revenue (US$ Million) in Diagnostic Biomarkers Business of Banyan Biomarkers, Inc (2019-2024)
Table 85. Banyan Biomarkers, Inc Recent Developments
Table 86. Biomedical Corp Basic Information List
Table 87. Biomedical Corp Description and Business Overview
Table 88. Biomedical Corp Diagnostic Biomarkers Products, Services and Solutions
Table 89. Revenue (US$ Million) in Diagnostic Biomarkers Business of Biomedical Corp (2019-2024)
Table 90. Biomedical Corp Recent Developments
Table 91. Key Raw Materials Lists
Table 92. Raw Materials Key Suppliers Lists
Table 93. Diagnostic Biomarkers Downstream Customers
Table 94. Diagnostic Biomarkers Distributors List
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
Table 98. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Diagnostic Biomarkers Product Picture
Figure 2. Global Diagnostic Biomarkers Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Diagnostic Biomarkers Sales Value (2019-2030) & (US$ Million)
Figure 4. Diagnostic Biomarkers Report Years Considered
Figure 5. Global Diagnostic Biomarkers Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Diagnostic Biomarkers Revenue in 2023
Figure 7. Diagnostic Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Safety Biomarkers Picture
Figure 9. Efficacy Biomarkers Picture
Figure 10. Validation Biomarkers Picture
Figure 11. Global Diagnostic Biomarkers Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Diagnostic Biomarkers Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Hospitals
Figure 14. Product Picture of Cancer Research Institutes
Figure 15. Product Picture of Diagnostic Labs
Figure 16. Global Diagnostic Biomarkers Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Diagnostic Biomarkers Sales Value Market Share by Application, 2023 & 2030
Figure 18. North America Diagnostic Biomarkers Sales Value (2019-2030) & (US$ Million)
Figure 19. North America Diagnostic Biomarkers Sales Value by Country (%), 2023 VS 2030
Figure 20. Europe Diagnostic Biomarkers Sales Value (2019-2030) & (US$ Million)
Figure 21. Europe Diagnostic Biomarkers Sales Value by Country (%), 2023 VS 2030
Figure 22. Asia Pacific Diagnostic Biomarkers Sales Value (2019-2030) & (US$ Million)
Figure 23. Asia Pacific Diagnostic Biomarkers Sales Value by Country (%), 2023 VS 2030
Figure 24. South America Diagnostic Biomarkers Sales Value (2019-2030) & (US$ Million)
Figure 25. South America Diagnostic Biomarkers Sales Value by Country (%), 2023 VS 2030
Figure 26. Middle East & Africa Diagnostic Biomarkers Sales Value (2019-2030) & (US$ Million)
Figure 27. Middle East & Africa Diagnostic Biomarkers Sales Value by Country (%), 2023 VS 2030
Figure 28. Key Countries/Regions Diagnostic Biomarkers Sales Value (%), (2019-2030)
Figure 29. United States Diagnostic Biomarkers Sales Value, (2019-2030) & (US$ Million)
Figure 30. United States Diagnostic Biomarkers Sales Value by Type (%), 2023 VS 2030
Figure 31. United States Diagnostic Biomarkers Sales Value by Application (%), 2023 VS 2030
Figure 32. Europe Diagnostic Biomarkers Sales Value, (2019-2030) & (US$ Million)
Figure 33. Europe Diagnostic Biomarkers Sales Value by Type (%), 2023 VS 2030
Figure 34. Europe Diagnostic Biomarkers Sales Value by Application (%), 2023 VS 2030
Figure 35. China Diagnostic Biomarkers Sales Value, (2019-2030) & (US$ Million)
Figure 36. China Diagnostic Biomarkers Sales Value by Type (%), 2023 VS 2030
Figure 37. China Diagnostic Biomarkers Sales Value by Application (%), 2023 VS 2030
Figure 38. Japan Diagnostic Biomarkers Sales Value, (2019-2030) & (US$ Million)
Figure 39. Japan Diagnostic Biomarkers Sales Value by Type (%), 2023 VS 2030
Figure 40. Japan Diagnostic Biomarkers Sales Value by Application (%), 2023 VS 2030
Figure 41. South Korea Diagnostic Biomarkers Sales Value, (2019-2030) & (US$ Million)
Figure 42. South Korea Diagnostic Biomarkers Sales Value by Type (%), 2023 VS 2030
Figure 43. South Korea Diagnostic Biomarkers Sales Value by Application (%), 2023 VS 2030
Figure 44. Southeast Asia Diagnostic Biomarkers Sales Value, (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Diagnostic Biomarkers Sales Value by Type (%), 2023 VS 2030
Figure 46. Southeast Asia Diagnostic Biomarkers Sales Value by Application (%), 2023 VS 2030
Figure 47. India Diagnostic Biomarkers Sales Value, (2019-2030) & (US$ Million)
Figure 48. India Diagnostic Biomarkers Sales Value by Type (%), 2023 VS 2030
Figure 49. India Diagnostic Biomarkers Sales Value by Application (%), 2023 VS 2030
Figure 50. Diagnostic Biomarkers Industrial Chain
Figure 51. Diagnostic Biomarkers Manufacturing Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Smart Potentiometric Titrator - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Multifunctional Zeta Potential Analyzer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Ultrapure Water pH Sensor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232